Archive: Early Investing
Page:
Nothing Is Immune to Disruption – Including Breakfast
By Vin Narayanan on November 16, 2019
No industry is safe from disruption. Even milk and orange juice are in trouble.
Two Ways to Resolve the Opioid Crisis
By Andy Gordon on November 13, 2019
More than 400,000 Americans have died from opioid overdoses. But there’s a solution - and two different methods to approach it.
Veterans Are Ready for Medical Marijuana
By Allison Brickell on November 11, 2019
A recent survey shows a huge number of veterans are interested in medical marijuana as a treatment option. Which means the current U.S. Department of Veterans Affairs marijuana policy needs a major update.
Mailbag: Understanding Startup Investing Rounds, Avoiding Uber and Lyft
By Early Investing on November 10, 2019
In this week’s Mailbag, the Early Investing team addresses startup funding rounds and whether Uber and Lyft are good buys.
News Fix: CBD Products Could Still Make You Fail a Drug Test
By Vin Narayanan on November 9, 2019
In the news this week: New York hemp farmers get a break, Saudi Arabia backs Travis Kalanick again and David Marcus says bitcoin isn’t a currency.
Cannabis Isn’t Going Anywhere
By Adam Sharp on November 8, 2019
Cannabis stocks are down, but this industry is still booming. If you can ride out the bear market and buy the dip, you’ll be sitting pretty long term.
The Deep, Dark Hole of Drug Addiction
By Andy Gordon on November 6, 2019
The opioid crisis has taken thousands of lives. And Andy Gordon has experienced the damage firsthand. But there is hope for a better future.
Mailbag: Why Bitcoin Is Still Crushing Altcoins and Startup Deal Flow Is Better Than Ever
By Early Investing on November 3, 2019
In this week’s Mailbag, the Early Investing team explains why altcoins are underperforming and how today’s startup deal flow is better than ever.
News Fix: Who Watches the Watchers?
By Vin Narayanan on November 2, 2019
In the news this week: Colleges become legal battlegrounds for cannabis, China praises blockchain and the Fix ponders who watches the watchers.
Buy Pot Stocks While Prices Are Low
By Adam Sharp on November 1, 2019
Marijuana stocks have taken a big hit across the board. That means they’re a great buying opportunity.
The Opioid Crisis Cost Us Almost $200 Billion Last Year
By Andy Gordon on October 30, 2019
The opioid crisis has cost American families, employers and the government billions of dollars. And we’re just beginning to see drug companies be held accountable. But there’s a silver lining.
Everyone Is Googling CBD
By Allison Brickell on October 28, 2019
Americans are Googling cannabidiol and CBD more than ever. This increased interest is another reason we desperately need marijuana reform.
Mailbag: Defining Reasonable Revenue Growth
By Early Investing on October 27, 2019
In this week’s Mailbag, the Early Investing team explains reasonable revenue growth numbers and underperforming IPOs.
News Fix: The Two-Minute Drill Version
By Vin Narayanan on October 26, 2019
In the news this week: Adam Neumann gets a hefty severance package, Indian startups have a record year and the Senate finally starts thinking about marijuana research.
How Will We Deal With All the Debt?
By Adam Sharp on October 25, 2019
Today, we explore the options that countries around the world have for paying off their unsustainable debt.
China’s Industrial Espionage Is Bad Policy
By Andy Gordon on October 23, 2019
China is in the news again for industrial espionage. And it’s a reflection of how far off course the country has gotten.